Survivorship Plans and Outcomes in Underserved Breast Cancer Survivors RCT
21 Years
N/A
Female
Breast Cancer
Trial Information
Survivorship Plans and Outcomes in Underserved Breast Cancer Survivors RCT
Inclusion Criteria:
- Female
- 21 years of age or older
- English- or Spanish-speaking
- Diagnosis of ductal carcinoma in situ (DCIS) or Stage I, II, or III BC for the first
time
- 12 months post-diagnosis
- At least 1 month post-chemotherapy completion
Exclusion Criteria:
- Previous cancer except non-melanomatous skin cancers or in situ non-breast cancers
- Pregnant and lactating women
- Patients receiving parenteral anti-cancer therapy, except trastuzumab
- Clinically apparent cognitive or psychiatric impairment
- Participation in another research study
- Current treatment for another cancer
- Male
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research
Outcome Measure:
Provider Adherence Score (PAS)
Outcome Description:
Discussion and implementation of recommended breast cancer (BC) survivorship care, including surveillance and the evaluation and management of BC treatment-related symptoms, bone health, weight, vasomotor symptoms, mammography, clinical breast examinations, and depression, as well as discussion of the patient's primary BC-related concern.
Outcome Time Frame:
One year post-intervention
Safety Issue:
No
Principal Investigator
Rose C Maly, MD, MSPH
Investigator Role:
Principal Investigator
Investigator Affiliation:
University of California, Los Angeles
Authority:
United States: Institutional Review Board
Study ID:
1R01CA140481
NCT ID:
NCT01627366
Start Date:
August 2012
Completion Date:
September 2015
Related Keywords:
- Breast Cancer
- Breast Neoplasms
Name | Location |
|---|---|
| UCLA | Los Angeles, California 90095 |
